International Network of VENous Thromboembolism Clinical Research Networks

RAPID COVID COAG

Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic

Registration:

NCT04362085

Sponsors:

St. Michael's Hospital, Toronto

Collaborator: University of Vermont Medical Center

Status:

Recruiting 

Design

This study is a 2-arm, parallel, pragmatic, multi-centre, open-label randomized controlled trial to determine the effect of therapeutic anticoagulation on the composite outcome of ICU admission, invasive mechanical ventilation and/or death in hospitalized patients with COVID-19.

Participating Sites

CanVECTOR logo

Lead Network:

CanVECTOR
Flag of Canada

Countries:

Canada, The Netherlands, USA,

Lead Investigators

Dr. Michelle Sholzberg, MD, MDCM

Michelle.Sholzberg@unityhealth.to

Subscribe

* indicates required

Contact Permissions

Please select the ways you would like to hear from INVENT Network:

Contact Permissions

By clicking below to subscribe, you agree to the terms of our privacy policy.